- Home
- TARA vs ELLO Comparison
TARA vs ELLO Comparison
Compare TARA & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TARA | ELLO |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.1M | 255.4M |
| IPO Year | 2014 | 1998 |
Fundamental Metrics
Financial Performance| Metric | TARA | ELLO |
|---|---|---|
| Price | $3.97 | $20.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $24.40 | N/A |
| AVG Volume (30 Days) | ★ 337.6K | 2.5K |
| Earning Date | 05-01-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.02 | $17.00 |
| 52 Week High | $7.82 | $30.34 |
Technical Indicators
Market Signals| Indicator | TARA | ELLO |
|---|---|---|
| Relative Strength Index (RSI) | 49.92 | 51.88 |
| Support Level | $3.73 | $19.31 |
| Resistance Level | $4.17 | $20.96 |
| Average True Range (ATR) | 0.14 | 0.65 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 59.78 | 38.89 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions. Geographically, the company operates in segments: Italy; Spain; USA; Netherland and Israel. It derives maximum revenue from Spain.